Recombinant Modified Vaccinia Virus Ankara Generating Excess Early Double-Stranded RNA Transiently Activates Protein Kinase R and Triggers Enhanced Innate Immune Responses
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Recombinant Modified Vaccinia Virus Ankara Generating Excess Early Double-Stranded RNA Transiently Activates Protein Kinase R and Triggers Enhanced Innate Immune Responses
Authors
Keywords
-
Journal
JOURNAL OF VIROLOGY
Volume 88, Issue 24, Pages 14396-14411
Publisher
American Society for Microbiology
Online
2014-10-09
DOI
10.1128/jvi.02082-14
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Virological View of Innate Immune Recognition
- (2012) Akiko Iwasaki Annual Review of Microbiology
- Poxviruses Deploy Genomic Accordions to Adapt Rapidly against Host Antiviral Defenses
- (2012) Nels C. Elde et al. CELL
- Protein Kinase PKR Amplification of Interferon β Induction Occurs through Initiation Factor eIF-2α-mediated Translational Control
- (2012) Christopher S. McAllister et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- MVA and NYVAC as Vaccines against Emergent Infectious Diseases and Cancer
- (2011) Carmen E. Gomez et al. CURRENT GENE THERAPY
- RIG-I-like receptors: cytoplasmic sensors for non-self RNA
- (2011) Hiroki Kato et al. IMMUNOLOGICAL REVIEWS
- The Vaccinia Virus O1 Protein Is Required for Sustained Activation of Extracellular Signal-Regulated Kinase 1/2 and Promotes Viral Virulence
- (2011) M. Schweneker et al. JOURNAL OF VIROLOGY
- IFIT1 is an antiviral protein that recognizes 5′-triphosphate RNA
- (2011) Andreas Pichlmair et al. NATURE IMMUNOLOGY
- A Candidate HIV/AIDS Vaccine (MVA-B) Lacking Vaccinia Virus Gene C6L Enhances Memory HIV-1-Specific T-Cell Responses
- (2011) Juan García-Arriaza et al. PLoS One
- Protein Kinase R Contributes to Immunity against Specific Viruses by Regulating Interferon mRNA Integrity
- (2010) Oliver Schulz et al. Cell Host & Microbe
- Concomitant type I IFN receptor-triggering of T cells and of DC is required to promote maximal modified vaccinia virus Ankara-induced T-cell expansion
- (2010) Theresa Frenz et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Viral Double-stranded RNAs from Vaccinia Virus Early or Intermediate Gene Transcripts Possess PKR Activating Function, Resulting in NF-κB Activation, When the K1 Protein Is Absent or Mutated
- (2010) Kristen L. Willis et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- New Insights into the Role of RNase L in Innate Immunity
- (2010) Arindam Chakrabarti et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- Roles of Vaccinia Virus Genes E3L and K3L and Host Genes PKR and RNase L during Intratracheal Infection of C57BL/6 Mice
- (2010) A. D. Rice et al. JOURNAL OF VIROLOGY
- Immediate-Early Expression of a Recombinant Antigen by Modified Vaccinia Virus Ankara Breaks the Immunodominance of Strong Vector-Specific B8R Antigen in Acute and Memory CD8 T-Cell Responses
- (2010) K. Baur et al. JOURNAL OF VIROLOGY
- Introduction of the Six Major Genomic Deletions of Modified Vaccinia Virus Ankara (MVA) into the Parental Vaccinia Virus Is Not Sufficient To Reproduce an MVA-Like Phenotype in Cell Culture and in Mice
- (2010) C. Meisinger-Henschel et al. JOURNAL OF VIROLOGY
- RIGorous Detection: Exposing Virus Through RNA Sensing
- (2010) J. Rehwinkel et al. SCIENCE
- Regulation of Adaptive Immunity by the Innate Immune System
- (2010) A. Iwasaki et al. SCIENCE
- PKR acts early in infection to suppress Semliki Forest virus production and strongly enhances the type I interferon response
- (2009) G. Barry et al. JOURNAL OF GENERAL VIROLOGY
- Viral host-range factor C7 or K1 is essential for modified vaccinia virus Ankara late gene expression in human and murine cells, irrespective of their capacity to inhibit protein kinase R-mediated phosphorylation of eukaryotic translation initiation factor 2
- (2009) S. Backes et al. JOURNAL OF GENERAL VIROLOGY
- Modified vaccinia Ankara strains with identical coding sequences actually represent complex mixtures of viruses that determine the biological properties of each strain
- (2009) Mark Suter et al. VACCINE
- Modified vaccinia virus Ankara can activate NF-κB transcription factors through a double-stranded RNA-activated protein kinase (PKR)-dependent pathway during the early phase of virus replication
- (2009) Heather E. Lynch et al. VIROLOGY
- Innate Immune Sensing of Modified Vaccinia Virus Ankara (MVA) Is Mediated by TLR2-TLR6, MDA-5 and the NALP3 Inflammasome
- (2009) Julie Delaloye et al. PLoS Pathogens
- IMVAMUNE®: modified vaccinia Ankara strain as an attenuated smallpox vaccine
- (2008) Jeffrey S Kennedy et al. Expert Review of Vaccines
- Induction of Protein Kinase PKR-dependent Activation of Interferon Regulatory Factor 3 by Vaccinia Virus Occurs through Adapter IPS-1 Signaling
- (2008) Ping Zhang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The RNA-activated Protein Kinase Enhances the Induction of Interferon-β and Apoptosis Mediated by Cytoplasmic RNA Sensors
- (2008) Christopher S. McAllister et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Inhibition of IκB Kinase by Vaccinia Virus Virulence Factor B14
- (2008) Ron A.-J. Chen et al. PLoS Pathogens
- Kinetic analysis of a complete poxvirus transcriptome reveals an immediate-early class of genes
- (2008) E. Assarsson et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Antagonizing activity of vaccinia virus E3L against human interferons in Huh7 cells
- (2008) Janilyn Arsenio et al. VIROLOGY
- Identification from diverse mammalian poxviruses of host-range regulatory genes functioning equivalently to vaccinia virus C7L
- (2007) Xiangzhi Meng et al. VIROLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started